Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/10/2019 |
| Start Date: | March 2016 |
| End Date: | December 2020 |
Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants to Timolol Maleate Ophthalmic Solution, USP, 0.5%
This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant
to timolol ophthalmic solution.
to timolol ophthalmic solution.
This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant
to timolol ophthalmic solution in patients with open-angle glaucoma. Study assessments will
include IOP and medication use as well as safety parameters.
to timolol ophthalmic solution in patients with open-angle glaucoma. Study assessments will
include IOP and medication use as well as safety parameters.
Inclusion Criteria:
- Open angle glaucoma
Exclusion Criteria:
- Uveitic, neovascular, or angle closure glaucoma; or glaucoma associated with vascular
disorders.
- Functionally significant visual field loss, including severe nerve fiber bundle
defects.
- Prior glaucoma surgery.
- Uncontrolled systemic disease, pregnant females or those planning a pregnancy.
- Other ocular status conditions, etc.
We found this trial at
1
site
Click here to add this to my saved trials
